dronabinol has been researched along with HbS Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, N; Bouyer, G; Connes, P; Egée, S; Esperti, S; Giustina Rotordam, M; Hatem, A; Kaestner, L; Maurer, F; Murciano, N; Nader, E; Pérès, L; Qiao, M | 1 |
| Fazzari, FGT; Maida, V; Shi, RB; Zomparelli, LM | 1 |
2 other study(ies) available for dronabinol and HbS Disease
| Article | Year |
|---|---|
Adverse effects of delta-9-tetrahydrocannabinol on sickle red blood cells.
Topics: Anemia, Sickle Cell; Dronabinol; Erythrocytes; Humans | 2023 |
A new treatment paradigm for sickle cell disease leg ulcers: Topical cannabis-based medicines.
Topics: Administration, Cutaneous; Adult; Anemia, Sickle Cell; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Female; Flavonoids; Humans; Leg Ulcer; Phytotherapy; Skin; Terpenes; Wound Healing | 2021 |